Plasma adrenomedullin levels were extremely elevated in sepsis patients admitted to ICU and correlated with disease severity, suggesting its role in sepsis-related blood pressure drops.
Extremely elevated in sepsisPlasma adrenomedullin levels in septic ICU patients were dramatically higher than in healthy individuals
What the researchers found
Plasma adrenomedullin concentrations were extremely elevated in septic ICU patients compared to healthy controls, correlating with disease severity.
Why it matters
Understanding which peptides drive the fatal blood pressure collapse in sepsis could lead to targeted treatments. Adrenomedullin's vasodilatory properties make it a key suspect in sepsis pathophysiology.
How the study worked
Cross-sectional study measuring plasma immunoreactive adrenomedullin levels in 12 septic patients upon ICU admission, compared to healthy controls.
What this study cannot tell us
Small sample (12 patients). Cross-sectional design cannot determine whether adrenomedullin elevation is a cause or consequence of sepsis. Correlation with severity doesn't prove causation.
How to read the evidence
Preliminary human evidence from a small ICU cohort. Demonstrates the association but cannot establish causation between adrenomedullin and sepsis outcomes.
When this study was published
Published in 1996, this was an early study establishing adrenomedullin's role in sepsis. It has since been validated by larger studies and clinical trials.
The bigger picture
Adrenomedullin has since become recognized as both a biomarker and potential therapeutic target in sepsis, with ongoing clinical trials of adrenomedullin-binding antibodies for septic shock treatment.
Questions still open
- Is adrenomedullin a driver of septic vasodilation or a compensatory protective response?
- Could adrenomedullin levels predict sepsis outcomes and guide treatment?
Common questions
What is adrenomedullin?
Why does sepsis cause blood pressure to drop?
Read the original research
Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis.
The Journal of clinical endocrinology and metabolism, 81(4), 1449-53
Citation
Hirata, Y; Mitaka, C; Sato, K; Nagura, T; Tsunoda, Y; Amaha, K; Marumo, F. (1996). Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis.. The Journal of clinical endocrinology and metabolism, 81(4), 1449-53.